Egalet Corp is a listed company. Its directors and officers file their transactions with SEC (Form 4). Egalet Corp has had no insider filing for more than a year; the last one goes back to 22 May 2020.
Since 2016, the database holds no purchases and 23 sales by insiders of the company.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2019 · cache
25 of 105 declarations
Egalet Corp is a pharmaceutical company focused on developing treatments for pain management. It is listed on NASDAQ under the symbol Egal.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2018 | 30.4 m USD | -95.5 m USD | n.d. | 10-K |
| Dec 2017 | 26.1 m USD | -69.4 m USD | n.d. | 10-K |
| Dec 2016 | 17.0 m USD | -90.6 m USD | n.d. | 10-K |
| Dec 2015 | 22.8 m USD | -57.9 m USD | n.d. | 10-K |
| Dec 2014 | 1.9 m USD | n.d. | n.d. | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.